SCHEMBL2933790

SCHEMBL2933790

Cc1ccc(-c2c(N)cccc2O)cc1[N+](=O)[O-]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.50
ALDH1A1 P00352 3/20 0.50
CYP3A4 P08684 2/20 0.50
RECQL P46063 1/20 0.50
MEN1 O00255 5/20 0.45
KMT2A Q03164 5/20 0.45
MAPT P10636 5/20 0.45
POLB P06746 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
GPR35 Q9HC97 1/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
CTDSP1 Q9GZU7 1/20 0.40
HSD17B10 Q99714 2/20 0.40
MAPK1 P28482 2/20 0.40
LMNA P02545 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2939532 0.83 PDGFRB (0.44) TSHRALDH1A1CYP3A4MEN1KMT2A
SCHEMBL2938189 0.80 KIF11 (0.51) ALDH1A1CYP3A4MEN1KMT2AMAPT
SCHEMBL2937049 0.79 MCL1 (0.41) TSHRALDH1A1CYP3A4MEN1KMT2A
SCHEMBL2933331 0.77 GAA (0.51) TSHRALDH1A1MAPTTDP1LMNA
SCHEMBL2932844 0.76 GAA (0.50) ALDH1A1RECQLMEN1KMT2AMAPT
SCHEMBL5685395 0.75 TSHR (0.68) TSHRALDH1A1CYP3A4RECQLMEN1
SCHEMBL27262879 0.75 MAPK1 (0.54) TSHRALDH1A1CYP3A4RECQLMEN1
SCHEMBL2940670 0.75 TSHR (0.46) TSHRALDH1A1CYP3A4MEN1KMT2A
SCHEMBL7190826 0.75 TSHR (0.64) TSHRALDH1A1CYP3A4RECQLMEN1
Hydrochloric Acid SCHEMBL5687862 0.74 TSHR (0.66) TSHRALDH1A1CYP3A4RECQLMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1494995-B1 3-AMINOPHENOL DERIVATIVES SUBSTITUTED IN THE 2-POSITION, AND DYES CONTAINING THESE COMPOUNDS PROCTER & GAMBLE (US) 2010-09-22 EP claimed
US-7033401-B2 3-Aminophenol derivatives substituted in the 2-position, and dyes containing these compounds WELLA AG (DE) 2006-04-25 US claimed
US-20040147515-A1 3-Aminophenol derivatives substituted in the 2-position, and dyes containing these compounds WELLA AKTIENGESELLSCHAFT (DE) 2004-07-29 US claimed
EP-1494995-B1 3-AMINOPHENOL DERIVATIVES SUBSTITUTED IN THE 2-POSITION, AND DYES CONTAINING THESE COMPOUNDS PROCTER & GAMBLE (US) 2010-09-22 EP disclosed
US-7033401-B2 3-Aminophenol derivatives substituted in the 2-position, and dyes containing these compounds WELLA AG (DE) 2006-04-25 US disclosed
US-20040147515-A1 3-Aminophenol derivatives substituted in the 2-position, and dyes containing these compounds WELLA AKTIENGESELLSCHAFT (DE) 2004-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147515-A1 3-Aminophenol derivatives substituted in the 2-position, and dyes containing these compounds ALPP, TYR, RB1 TSHR 1081/4885ALDH1A1 107/4885CYP3A4 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.